IRUS-ANZ has moved. From January 2022, new monthly statistics will only be added to the IRUS R5 service. This site is archived. All statistics up to December 2021 will remain available on this site.

Item Statistics

Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis

RepositoryUniversity of Queensland [UQ eSpace]
URLhttps://espace.library.uq.edu.au/view/UQ:381086
Author(s)Kalincik, Tomas; Horakova, Dana; Spelman, Tim; Jokubaitis, Vilija; Trojano, Maria; Lugaresi, Alessandra; Izquierdo, Guillermo; Rozsa, Csilla; Grammond, Pierre; Alroughani, Raed; Duquette, Pierre; Girard, Marc; Pucci, Eugenio; Lechner-Scott, Jeannette; Sle
Item typeArticle
JournalAnnals of Neurology, Print_ISSN:0364-5134, Online_ISSN:1531-8249
DOIhttps://doi.org/10.1002/ana.24339

Sorry - we've not seen any usage for this item in the last six weeks...

Jisc logo Cranfield logo CAVAL logo